Dungog, Argie Lou .
HRN: 24-08-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/21/2023
11/28/2023
IV
4.5g
Q8
Nephrotic Syndrome
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes